1. Treatment of acute nonlymphocytic leukemia: Use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens;Preisler;Blood,1979
2. S-Phase cells of the leukemic cell cycle sensitive to 1-B-D-arabinofuranosylcytosine at a high dose level;Smets;Cancer Res.,1985
3. Detection of 1-B-D-arabinofuranosylcytosine incorporation into DNA in vivo;Spriggs;Cancer Res.,1987
4. Recognition of a subgroup of patients with acute myeloid leukemia (AML) who will not respond to therapy with high dose cytosine arabinoside using bromodeoxyuridine and tritiated araC in vitro;Raza,1989
5. Measurement of strand breaks and crosslinks by alkaline elution;Kohn,1981